The PennZone

  • Home
  • Non-profit
  • Books
  • Entertainment
  • Music
  • Marketing
  • Legal
  • Health
  • Artificial Intelligence

Greenphire Enhances Patient Convenience Solutions, Supporting Clinical Trial Sites with Recruitment and Retention Worldwide
The PennZone/10123847

Trending...
  • Growth Story Expands: $54.6M Contract, $30M Revenue Run Rate, 800+ Customers, 50+ Patents & New AI Cybersecurity Products for Cycurion, Inc $CYCU
  • Nutriband Inc. (N A S D A Q: NTRB) Breaks Into Uncharted Territory: 52-Week High Eclipsed as Shares Surge 22% —AVERSA™ Puts Investors on High Alert
  • Dr. Jay Johannigman Returns to Cincinnati Following 46 Years of Military Service
KING OF PRUSSIA, Pa., May 4, 2021 /PRNewswire/ -- Greenphire, the global leader in financial lifecycle management for clinical trials, today announced sharp growth of its patient convenience solutions, ClinCard and ConneX, worldwide. The company, which now serves investigator sites in more than 70 countries, also made strategic enhancements to its solutions that support adoption, training, and usage of technologies.

ConneX®,  the trusted participant travel service designed to eliminate logistical barriers to participation in global clinical trials, has now facilitated travel in 34 countries, with the ability to arrange travel and accommodations worldwide. Notably, after going live with in-country support in China, Greenphire has already executed more than 200 patient itineraries. In addition, the number of studies using ConneX increased by 62% and the number of itineraries by 40% since the start of 2020, with notable increases in France and Russia.

Greenphire has also continued to evolve its ClinCard solution, the industry-leading method for automating participant payments and reimbursements, driving operational efficiency for sites and improved experience for participants around the world. The ClinCard portal is now translated into 17 different languages, including French, Polish, and Spanish. The company also initiated a dedicated site training team with EU and APAC time zones supported, demonstrating its commitment and motivation to provide a high quality and user-friendly experience for sites around the world.

More on The PennZone
  • Harvard Educated Board Certified Endodontist Joins Pearlfection Dentistry
  • NYC Banners Delivers High-Stakes UN General Assembly Backdrop for the US Department of State Event
  • OneVizion Appoints Energy Infrastructure Executive Walt Farrell to Board of Directors
  • Tampa Bay Reporter Launches with a Mission to Deliver Local News with National Reach
  • "JACKIE the STRIPPER," Starring Charlotte Kirk and The PUSSYCAT DOLLS' Kimberly Wyatt, Now Streaming on PRIME

"COVID-19 was a catalyst that accelerated the clinical trial industry towards embracing technology solutions, such as ClinCard and ConneX," said Jim Murphy, CEO, Greenphire. "Sponsors, CROs and sites quickly appreciated the immense benefits of adding innovative solutions to support their trials, such as higher patient engagement and retention and improved operational efficiencies. We are proud to support this digital movement and enhance the experience for sites in every corner of the globe."

Recognized as leaders in clinical digital innovations in the United Kingdom, having their EU headquarters in Nottingham and more than 1,000 sites supported in the country, Greenphire executives have been asked to host an interactive panel on this growing trend.

Hosted by the Society for Clinical Research Sites (SCRS), the one-hour session titled: Digital Innovation in Clinical Trials: A Conversation with UK Stakeholders, will also feature the unique perspectives of clinical trial site, The University of Aberdeen, and advocate and patient engagement advisor, Trishna Bharadia.

This virtual event is scheduled for May 4, 2021 at 10:00 AM ET and will take a deep dive into current trends and how technology, together with training, is driving the future of clinical trials.

Presenters include:
  • Angela La Ronde, Panel Moderator, Director of Relationship Management, Greenphire UK
  • Trishna Bharadia, Advocate and Patient Engagement Advisor
  • Shaun Treweek, Professor, University of Aberdeen
  • Ben Gordon, Site Trainer, Greenphire UK

For more information or to register for the event visit: https://bit.ly/3tLmfws

More on The PennZone
  • Migguel Anggelo Celebrates the Immigrant Experience, Latino Identity, and the Power of Iconic Latin Rhythms During Hispanic Heritage Month
  • Indianapolis Criminal Defense Firm Rigney Law LLC Relaunches Criminal Law Podcast "Tales from the Brown Desk"
  • 3ptechies Makes Its Articles Audio-Ready With Instaread Voice Technology
  • Genuine Hospitality, LLC Selected to Operate Fairfield Inn & Suites Tampa Wesley Chapel
  • Pregis to Highlight EPR Expertise, Sustainable Packaging Solutions and Live Automation Demonstrations at Pack Expo International 2026

Greenphire is also a co-sponsor of the 11th Annual OCT Europe (Outsourcing in Clinical Trials). The virtual event, hosted from May 5-6, 2021, will center on how to leverage partnerships and expertise to maximize trial success. For more information, visit: https://www.arena-international.com/octeurope/

About Greenphire
Greenphire is the leader in global clinical trial financial process automation. Greenphire's best-in-class solutions optimize clinical trial performance by streamlining payment and logistical workflows from sponsors and CROs to sites and patients. Greenphire's EnvisiXTM, eClinicalGPS, ClinCard and ConneX solutions easily handle any type of trial design and complexity, resulting in more accurate and compliant payments and simplified travel globally for both sites and patients. The choice of industry leaders worldwide, Greenphire provides better performance and better data, resulting in better trials. Learn more at www.greenphire.com.

Media Contact:
Alyson Kuritz
908-892-7149
[email protected]

SOURCE Greenphire

Related Links

http://www.greenphire.com
Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Nutriband (N A S D A Q: NTRB): Fighting Back Against the Fentanyl Crisis With a New Approach to Safer Transdermal Medicines
  • Curtis Salgado shares a love letter to the city of Chicago and Otis Rush with new single
  • Oral statement on the situation of Chairman Lee Man-hee in pretrial detention in the Republic of Korea
  • Names Are Not Important Asks What Remains When Identity Is Stripped of Labels
  • UVIFY Brings Advanced Autonomous Systems Research to IROS 2026 in Pittsburgh
  • Mad Darbarian is available for views as a Horror Host
  • Most Utah Deaths Never Reach the Medical Examiner. Postmortem Pathology Offers Salt Lake City a Private Autopsy Option
  • Virtually Tour Heritage at South Brunswick's Resort-Style Living - Experience Indoor and Outdoor Amenities at Your Fingertips
  • Derek Cook's Roofing Encourages Homeowners to Prepare for Fall Weather
  • Boston Industrial Solutions Expands Product Offering with Pad Printing Pads and Silicone for Custom Pad Manufacturing
  • Rodeo FX Originals Appoints Yvann Thibaudeau Head of Development & IP
  • Phoenix 5/7 Emerges as a Genre-Fluid Artist Collective
  • Massage Revolution Expands to Santa Monica With New Wilshire Boulevard Location
  • "Warrior Defined" Event Brings Men Together in Charlotte, With Calls for Events Across the U.S
  • Dion Abadi Publishes Free Collector Tips Hub for Art and Jewelry Buyers
  • World-Renowned Body Language Expert Mark Bowden Headlines INSPIRE Northwest 2026 in Wenatchee, WA
  • ASN Software Introduces New California CARS Act Dealer Updates
  • USA Air Management Marks 30 Years of Air Duct Cleaning in NJ Urges Homeowners to Schedule Dryer Vent Cleaning Before Heating Season
  • Dr. Jay Johannigman Returns to Cincinnati Following 46 Years of Military Service
  • Mud Morganfield Bares His Soul on 7" Single, 'Deep Gospel'

Popular on PennZone

  • Benny Turner Revisits Freddie King's Legacy for 50th Anniversary of His Passing - 248
  • Church Tradition Takes an Unexpected Turn at the Ford Community & Performing Arts Center - 216
  • GitKraken Names Jim Shaw CEO as Software Teams Move From AI Adoption to Multi-Agent Orchestration - 170
  • Brévant Guide Launches New National Restaurant Guide Across Canada - 139
  • VC Fast Pitch and Steamwork Ventures Bring Startup & Investor Networking Event to Santa Barbara on October 8 - 124
  • FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
  • SHI Introduces the RP-222B3S, Its Highest-Capacity 4K Pulse Tube Cryocooler
  • Sea Tales Strengthens U.S. Leadership Team as Retail Expansion Accelerates
  • Robert DeMaio, Phinge CEO to Speak at 30th IIPLA 2026 on Securing IP, User Data & Digital Sovereignty via Verified App-less Tech. Attend the Live Q&A!
  • Mandeville Pests May Pose Serious Health Risks for Your Family

Similar on PennZone

  • NIL Club Data Shows Brands Are Looking Beyond Follower Counts in College Sports
  • NYC Banners Delivers High-Stakes UN General Assembly Backdrop for the US Department of State Event
  • Genuine Hospitality, LLC Selected to Operate Fairfield Inn & Suites Tampa Wesley Chapel
  • Pregis to Highlight EPR Expertise, Sustainable Packaging Solutions and Live Automation Demonstrations at Pack Expo International 2026
  • Infinity Infusion Solutions Launches "Women Leading Infusion Care" Campaign for National Women in Business Month
  • HuskyTail Digital Puts AI to Work Behind the Scenes to Cut Client Turnaround Time
  • AI, Real-World Data "RWD" and U.S. Expansion Put Predictive Healthcare in Focus for POMDOCTOR Ltd. (N A S D A Q: POM)
  • $11.18 Million DARPA Award Ignites a Major New Catalyst as FDA, Robotic TMS and Commercialization Milestones Converge for NRx Pharmaceuticals, Inc
  • Nutriband (N A S D A Q: NTRB): Fighting Back Against the Fentanyl Crisis With a New Approach to Safer Transdermal Medicines
  • Most Utah Deaths Never Reach the Medical Examiner. Postmortem Pathology Offers Salt Lake City a Private Autopsy Option
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us